Results 211 to 220 of about 21,604,258 (289)
Prospects of Chimeric Antigen Receptor T-Cell Therapy in Myelofibrosis: From Immunopathogenesis to Therapeutic Strategies. [PDF]
Kong L +7 more
europepmc +1 more source
Designed Peptide Coacervates for Extracellular Antibody Targeting
Peptide‐based coacervates formed by liquid‐liquid phase separation provide a membraneless platform for therapeutic antibody delivery. Using Rituximab as a model, these coacervates enable efficient encapsulation, enhanced cell interactions, and provide partial protection from enzymatic proteolysis while maintaining low cytotoxicity.
Nofar Berman +4 more
wiley +1 more source
IFNγ-induced antigen loss in chimeric antigen receptor-T cell therapy. [PDF]
Cao M +10 more
europepmc +1 more source
The CD47–SIRPα axis has emerged as a critical innate immune checkpoint that suppresses macrophage‐mediated phagocytosis through a canonical “don't eat me” signal and enables tumor immune evasion. We comprehensively summarize the structural and biological features of CD47 and the molecular mechanisms underlying CD47‐mediated regulation of phagocytosis ...
Ruimei Zhou +4 more
wiley +1 more source
Efficacy and safety of CD30-targeted chimeric antigen receptor T-cell therapy for lymphoma: a meta-analysis. [PDF]
Shi J, Lu C, Song C, Wang Q.
europepmc +1 more source
Advances in research on layered double hydroxides for biomedical applications
Layered double hydroxides (LDHs) are pH‐responsive nanomaterials with broad biomedical applications. This review summarizes LDH synthesis methods and compares their advantages. It highlights LDHs' progress in cancer therapy, including chemo‐photothermal, chemo‐immunotherapy, and photodynamic‐immunotherapy combinations and their potential in bone repair.
Xinhui Yang +13 more
wiley +1 more source
Efficacy and safety of chimeric antigen receptor T-cell therapy for plasma cell leukemia. [PDF]
Hu C +12 more
europepmc +1 more source
Higher chimeric antigen receptor‐T expansion at day 7 is associated with improved progression‐free survival but also increased toxicity in axi‐cel treated patients with R/R large B‐cell lymphoma, independent of other baseline patient and disease characteristics.
Brydon Panozzo +17 more
wiley +1 more source
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination. [PDF]
Warmuth L +24 more
europepmc +1 more source

